| 2025/0113,794 | METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO ENHANCE THE YIELD AND QUALITY OF CUCUMBER FRUITS | Jan 03, 24 | Apr 10, 25 | CH Biotech R&D Co., Ltd. |
| 2025/0113,846 | CORN PROTEIN CONCENTRATE AND METHODS OF MANUFACTURING SAME | Dec 19, 24 | Apr 10, 25 | Cargill Incorporated |
| 2025/0114,339 | COMBINATION THERAPY COMPRISING A KRAS G12D INHIBITOR AND AN EGFR INHIBITOR | Oct 08, 24 | Apr 10, 25 | Not available |
| 2025/0114,358 | ALS TREATMENT USING INDUCED REGULATORY T (ITREG) CELLS | Oct 11, 24 | Apr 10, 25 | RAPA THERAPEUTICS, LLC |
| 2025/0114,391 | BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT | May 17, 24 | Apr 10, 25 | HiberCell, Inc. |
| 2025/0114,392 | BETA-GLUCAN IN COMBINATION WITH ANTI-CANCER AGENTS AFFECTING THE TUMOR MICRENVIRONMENT | May 20, 24 | Apr 10, 25 | HiberCell, Inc. |
| 2025/0114,400 | Application of SIRT1-7 protein in immunotherapy | Dec 30, 21 | Apr 10, 25 | Avenex Biosciences LTD. |
| 2025/0114,428 | DIPEPTIDOMIMETICS AS INHIBITORS OF HUMAN IMMUNOPROTEASOMES | May 03, 24 | Apr 10, 25 | Not available |
| 2025/0114,429 | VISTA ANTAGONIST AND METHODS OF USE | Jul 10, 24 | Apr 10, 25 | Not available |
| 2025/0114,432 | WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA | Dec 19, 24 | Apr 10, 25 | Not available |
| 2025/0114,433 | BINDING PROTEINS SPECIFIC FOR RAS NEOANTIGENS AND USES THEREOF | May 13, 24 | Apr 10, 25 | Not available |
| 2025/0114,443 | PROTEIN ANTIGENS THAT PROVIDE PROTECTION AGAINST PNEUMOCOCCAL COLONIZATION AND/OR DISEASE | Aug 09, 24 | Apr 10, 25 | Children's Medical Center Corporation |
| 2025/0114,446 | LOW-SUGAR CORONAVIRUS VACCINE AND METHODS THEREOF | Oct 08, 24 | Apr 10, 25 | Not available |
| 2025/0114,449 | STABLE ANTI-OSMR ANTIBODY FORMULATION | May 23, 24 | Apr 10, 25 | Not available |
| 2025/0114,450 | PHARMACEUTICAL COMBINATION CONTAINING ANTI-PD-1-ANTI-VEGFA BISPECIFIC ANTIBODY, AND USE THEREOF | Mar 10, 22 | Apr 10, 25 | Not available |
| 2025/0114,451 | REDUCING POLYSORBATE DEGRADATION IN PROTEIN FORMULATIONS BY LOW AMOUNTS OF CITRIC ACID | Jan 17, 23 | Apr 10, 25 | Not available |
| 2025/0114,452 | LAT ACTIVATING CHIMERIC ANTIGEN RECEPTOR T CELLS AND METHODS OF USE THEREOF | Aug 04, 22 | Apr 10, 25 | Not available |
| 2025/0114,454 | MODIFIED IMMUNE CELLS AND METHODS FOR USE THEREOF | Oct 30, 24 | Apr 10, 25 | Not available |
| 2025/0114,463 | LIVER-TARGETED DRUG AND USE THEREOF | Dec 22, 22 | Apr 10, 25 | HANMI PHARM. CO., LTD. |
| 2025/0114,467 | ANTI-DLL3 ANTIBODY AND PREPARATION METHOD THEREFOR, DRUG CONJUGATE AND APPLICATION THEREOF | Jul 29, 22 | Apr 10, 25 | Not available |